HR Execs on the Move

Phoenix Bio-Tech Corp

www.phoenixbiotech.com

 
Phoenix Bio-Tech Corp is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

R2 Technologies

Glacial Rx™ is the first age spot removal treatment that uses patented cooling technology to freeze melanin at the source, soothing your skin while effectively removing those annoying age spots.

Sunrise Labs

Sunrise Labs architects and implements innovative engineering solutions for ‘smart’ products that work. We are a product development company specializing in one-stop delivery of robust, reliable medical devices and industrial instrumentation.Eric, Laurin and Drew In 1992, Drew Sunstein founded our company to partner with clients and produce quality, practical, cost-effective design solutions with a sharp focus on time-to-market. We build products that work. Our products work for the end user, the manufacturer, and all service providers. With experience spanning the development progression, and a reputation for delivering on commitments, our team is the smart choice to tackle your product development challenges. Our engineers design quality in by fully understanding the requirements before designing or coding begins.  Our ISO 9001 and ISO 13485 certified processes are built to stand alone or work in adjunct to your quality systems.  Our facilities, services, and systems are flexible, allowing us to scale our efforts to support your needs and maximize efficiency. We honor our commitments and stand behind our engineering.  From idea to implementation, we build innovative engineering solutions that result in “smart” products that work.

Co-View Capital

Co-View Capital is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Technology Imaging Services

Technology Imaging Services is a Youngstown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.